.........................................................................................................................57 iv

7.0 Appendices...........................................................................................................................61

Albanese, G. et al. (2020) ‘Dynamic consent management for clinical trials via private blockchain technology', Journal of Ambient Intelligence and Humanized Computing. doi: 10.1007/s12652 020-01761-1.

Alshamsi, A. and Andras, P. (2019) ‘User Perception of Bitcoin Usability and Security across Novice Users'.

Bashir, I. (2017) Mastering Blockchain: Deeper insights into decentralization, cryptography, Bitcoin, and popular Blockchain frameworks. 2nd edn. Birmingham, UK: Packt Publishing.

Benchoufi, M., Porcher, R. and Ravaud, P. (2018) ‘Blockchain protocols in clinical trials: Transparency and traceability of consent', F1000Research, 6. doi: 10.12688/f1000research.10531.5.

Benchoufi, M. and Ravaud, P. (2017) ‘Blockchain Technology for Improving Clinical Research Quality', Trials, 18(1), p. 335. doi: 10.1186/s13063-017-2035-z.

Braun, V. and Clarke, V. (2006) ‘Using thematic analysis in psychology', Qualitative Research in Psychology. Routledge, 3(2), pp. 77-101. doi: 10.1191/1478088706qp063oa.

Burrell, G. and Morgan, G. (1979) Sociological Paradigms and Organisational Analysis: Elements of the Sociology of Corporate Life. 1 edition. London: Pearson Education.

Carlisle, J. B. (2017) ‘Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals', Anaesthesia, 72(8), pp. 944-952. doi: 10.1111/anae.13938.

ClinicalTrials.Gov (2020) Trends, Charts, and Maps - ClinicalTrials.gov, ClinicalTrials. Available at: https://clinicaltrials.gov/ct2/resources/trends (Accessed: 16 May 2020).

Crosby, M. (2016) ‘BlockChain Technology: Beyond Bitcoin', Applied Innovation Review, (2), p. 16.

European Parliament (2020) Blockchain and the General Data Protection Regulation. Brussels: European Parliamentary Research Service, pp. 1-101. Available at: https://www.europarl.europa.eu/RegData/etudes/STUD/2019/634445/EPRS_STU%282019%29 634445_EN.pdf (Accessed: 12 July 2020).

FDA (2013) ‘Guidance for Industry Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring'. Available at: https://www.fda.gov/media/116754/download.

FDA (2016) ‘Data Integrity and Compliance With CGMP Guidance for Industry'. Food and Drug Administration. Available at: https://www.fda.gov/files/drugs/published/Data-Integrity-and Compliance-With-Current-Good-Manufacturing-Practice-Guidance-for-Industry.pdf (Accessed: 21 June 2020).

Friar, H. S. and Kirsh, D. (2019) Why data integrity is important for the success of clinical trials, MassDevice. Available at: https://www.massdevice.com/why-data-integrity-is-important-forthe-success-of-clinical-trials/ (Accessed: 24 June 2020). George, S. L. (2016) ‘Research misconduct and data fraud in clinical trials: prevalence and causal factors', International Journal of Clinical Oncology, 21(1), pp. 15-21. doi: 10.1007/s10147-015 0887-3.

George, S. L. and Buyse, M. (2015) ‘Data fraud in clinical trials', Clinical investigation, 5(2), pp. 161-173. doi: 10.4155/cli.14.116.

Gupta, A. (2013) ‘Fraud and misconduct in clinical research: A concern', Perspectives in clinical research. (Perspectives in Clinical Research), 4(2). doi: 10.4103/2229-3485.111800.

Hirano, T. et al. (2020) ‘Data validation and verification using blockchain in a clinical trial for breast cancer', p. 30.

Hölbl, M. et al. (2018) ‘A Systematic Review of the Use of Blockchain in Healthcare', Symmetry, 10, p. 470. doi: 10.3390/sym10100470.

Holdowsky, J., Lele, N. and Lougheed, G. (2018) Many paths lead to blockchain adoption, and no two are alike, Deloitte Insights. Available at: https://www2.deloitte.com/us/en/insights/topics/understanding-blockchain-potential/globalblockchain-survey/2019-adoption-by-industry.html (Accessed: 8 July 2020).

Hume, S. et al. (2017) ‘Visualizing and Validating Metadata Traceability within the CDISC Standards', AMIA Summits on Translational Science Proceedings, 2017, pp. 158-165.

ICH (2018) ‘E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1) Guidance for Industry'. International Council for Harmonization. Available at: https://www.fda.gov/media/93884/download (Accessed: 13 May 2020).

Khin, N. A. et al. (2020) ‘Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop', Clinical Pharmacology and Therapeutics. doi: 10.1002/cpt.1794.

Krishnankutty, B. et al. (2012) ‘Data management in clinical research: An overview', Indian Journal of Pharmacology, 44(2), pp. 168-172. doi: 10.4103/0253-7613.93842.

Kuo, T.-T., Kim, H.-E. and Ohno-Machado, L. (2017) ‘Blockchain distributed ledger technologies for biomedical and health care applications', Journal of the American Medical Informatics Association. Oxford Academic, 24(6), pp. 1211-1220. doi: 10.1093/jamia/ocx068.

Lin, I.-C. and Liao, T.-C. (2017) ‘A survey of blockchain security issues and challenges', International Journal of Network Security, 19(5), pp. 653-659. doi: 10.6633/IJNS.201709.19(5).01.

Mackey, T. K. et al. (2019) ‘“Fit-for-purpose?” - challenges and opportunities for applications of blockchain technology in the future of healthcare', BMC Medicine. (Beyong Big Data to new Biomedical and Health Data Science), 17, pp. 1-17. doi: 10.1186/s12916-019-1296-7.

Mann, S. P. et al. (2020) ‘Blockchain, consent and prosent for medical research', Journal of Medical Ethics. Institute of Medical Ethics, pp. 1-7. doi: 10.1136/medethics-2019-105963.

MarketsandMarkets (2020) Blockchain Market Size, Growth, Trends and Forecast to 2025 | MarketsandMarkets, Blockchain Market by Component (Platform and Services), Provider (Application, Middleware, and Infrastructure), Type (Private, Public, and Hybrid), Organization Size, Application Area (BFSI, Government, IT & Telecom), and Region - Global Forecast to 2025. Available at: https://www.marketsandmarkets.com/Market-Reports/blockchain-technologymarket-90100890.html (Accessed: 12 August 2020).

Maslove, D. M. et al. (2018) ‘Using Blockchain Technology to Manage Clinical Trials Data: A Proof-of-Concept Study', JMIR Medical Informatics, 6(4). doi: 10.2196/11949.

MRC (2014) ‘MRC Policy and Procedure for Investigating Allegations of Research Misconduct'. Medical Research Council. Available at: https://mrc.ukri.org/documents/pdf/mrc-policy-onresearch-misconduct/ (Accessed: 29 June 2020).

Nakamoto, S. (2009) ‘Bitcoin: A Peer-to-Peer Electronic Cash System', p. 9.

Pocock, S. J. (2013) Clinical Trials: A Practical Approach. 1st edn. Wiley. Available at: https://www.amazon.co.uk/Clinical-Trials-Practical-Approach-Publications/dp/0471901555 (Accessed: 2 July 2020).

Sarmah, S. (2018) ‘Understanding Blockchain Technology', Computing Science and Engineering, 8(2), pp. 23-29. doi: 10.5923/j.computer.20180802.02.

Saunders, M. N. K., Lewis, P. and Thornhill, A. (2015) Research Methods for Business Students. 7 edition. New York: Pearson.

Scarso Borioli, G. and Couturier, J. (2018) ‘How blockchain technology can improve the outcomes of clinical trials', British Journal of Healthcare Management, 24, pp. 156-162. doi: 10.12968/bjhc.2018.24.3.156.

Segen's Medical Dictionary (2012) data integrity, TheFreeDictionary.com. Available at: https://medical-dictionary.thefreedictionary.com/data+integrity (Accessed: 24 June 2020).

Seife, C. (2015) ‘Research Misconduct Identified by the US Food and Drug Administration: Out of Sight, Out of Mind, Out of the Peer-Reviewed Literature', JAMA Internal Medicine, 175(4), p. 567. doi: 10.1001/jamainternmed.2014.7774.

Sertkaya, A. et al. (2016) ‘Key cost drivers of pharmaceutical clinical trials in the United States', Clinical Trials, 13(2), pp. 117-126. doi: 10.1177/1740774515625964.

Shamley, D. and Wright, B. (eds) (2017) A comprehensive and practical guide to clinical trials. London, United Kingdom; San Deigo, CA, United States: Elsevier/AP, Academic Press, an imprint of Elsevier.

Triall (2019) ‘A brief introduction to clinical trials', Insights by Triall.io, 3 July. Available at: https://insights.triall.io/a-brief-introduction-to-clinical-trials-medical-research-andpharmaceutical-innovation/ (Accessed: 2 July 2020).

Vujicic, D., Jagodic, D. and Ranđić, S. (2018) ‘Blockchain technology, bitcoin, and Ethereum: A brief overview', in. Cacak, Serbia: Faculty of Technical Sciences University of Kragujevac, pp. 1-6. doi: 10.1109/INFOTEH.2018.8345547.

WHO (2018) Clinical trials, Clinical Trials. Available at: https://www.who.int/westernpacific/health-topics/clinical-trials (Accessed: 26 June 2020).

Wong, C. H., Siah, K. W. and Lo, A. W. (2019) ‘Estimation of clinical trial success rates and related parameters', Biostatistics, 20(2), pp. 273-286. doi: 10.1093/biostatistics/kxx069. Wong, D. R., Bhattacharya, S. and Butte, A. J. (2019) ‘Prototype of running clinical trials in an untrustworthy environment using blockchain', Nature Communications. Nature Publishing Group, 10(1), pp. 1-8. doi: 10.1038/s41467-019-08874-y.

Zheng, Z. et al. (2017) ‘An Overview of Blockchain Technology: Architecture, Consensus, and Future Trends', in 2017 IEEE International Congress on Big Data (BigData Congress). 2017 IEEE International Congress on Big Data (BigData Congress), IEEE Computer Society, pp. 557- 564. doi: 10.1109/BigDataCongress.2017.85.

Zheng, Z. et al. (2018) ‘Blockchain challenges and opportunities: A survey', International Journal of Web and Grid Services, 14, p. 352. doi: 10.1504/IJWGS.2018.095647. Appendices